Mon.Jan 27, 2025

article thumbnail

An ALS treatment wave is approaching, and this biotech CEO is ready to surf

PharmaVoice

Coya Therapeutics is entering into a phase 2b study for its ALS, and the biotech’s CEO believes it’s on the cusp of a game changer.

264
264
article thumbnail

The biggest cause of death in the U.S. remains the same

STAT

  Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here.

170
170
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Natural killer cells, a rising alternative to CAR-T cell therapy

PharmaVoice

These innate immune cells may provide a safer, lower-cost option in cancer and autoimmune diseases.

article thumbnail

GSK backs £50m Oxford University cancer vaccine programme

pharmaphorum

A GSK alliance with Oxford University aims to identify precancerous changes in cells that could form the basis of preventive vaccines.

Vaccines 118
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Pfizer settles Biohaven kickback claims case for $59.7m

Pharmaceutical Technology

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.

98
article thumbnail

Pfizer offers $60m to settle prescriber kickback claims

pharmaphorum

Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.

102
102

More Trending

article thumbnail

Ascentage raises $126m in first biotech IPO of 2025

pharmaphorum

China's Ascentage completes the first US biotech IPO of 2025, raising $126m for its pipeline of small-molecule cancer drugs.

98
article thumbnail

Vedanta Biosciences reveals Phase 2 VE303 results

Pharma Times

Study highlights VE303's potential in reducing recurrent CDI

83
article thumbnail

Six life sciences real estate trends to watch in 2025

pharmaphorum

Stay ahead of the game by keeping an eye on these six life sciences real estate trends to watch in 2025. From AI integration to collaborative incubator spaces, the industry is evolving rapidly.

97
article thumbnail

Alligator Bioscience reports survival benefit of mitazalimab with mFOLFIRINOX

Pharma Times

Comparison shows improved survival rates for pancreatic cancer treatment

79
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

UK biotech Swarm lands with a T-cell therapy mission

pharmaphorum

UK firm Swarm Oncology launches with a T-cell therapy platform to treat solid tumours, with a Resolution Therapeutics co-founder in the pilot seat.

83
article thumbnail

Akero says MASH drug reverses liver damage in study, doubling shares

BioPharma Dive

Results showing Akero’s efruxifermin improved fibrosis by more than what Wall Street expected lifted the stock of both it and rival MASH developer 89bio.

69
article thumbnail

Tevogen Bio and Microsoft expand AI collaboration to PredicTcell tech

Pharmaceutical Technology

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance PredicTcell.

69
article thumbnail

Italian decision sets up launch of Oncopeptides' Pepaxti

pharmaphorum

Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.

63
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

The AI advantage in discovering new medicines 

Pharmaceutical Technology

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

64
article thumbnail

Sage rebuffs Biogen bid to take it over

BioPharma Dive

Sage’s board of directors said Biogen’s offer “undervalues” the company, but will explore other strategic alternatives to “maximize” shareholder value.

59
article thumbnail

FDA Accepts Review of Golimumab Biosimilar

Pharmaceutical Commerce

Known as AVT05, the Alvotech medication is a proposed biosimilar to Simponi, prescribed to treat various inflammatory conditions.

article thumbnail

Provepharm Recalls Phenylephrine Hydrochloride Injection

PharmaTech

One lot of Phenylephrine hydrochloride Injection, USP, 10 mg/mL is being recalled due to particulate matter found in a vial.

59
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Muscle-building drug improves body composition in obesity trial, Veru says

BioPharma Dive

Shares in Veru fell by nearly half following the news, despite positive results in preserving lean muscle mass.

59
article thumbnail

Behind the Headlines: Sana’s Type 1 Diabetes Breakthrough, Drug Price Negotiations, and More

PharmaTech

Brian Feth, Jonathan Grinstein, PhD, Beth Willers, and Laks Pernenkil go behind the headlines to discuss major news announcements made during the JP Morgan Healthcare Conference, a wave of new Medicare drug price negotiations, and more.

article thumbnail

MSD wins FDA priority review for Welireg in rare endocrine cancer

Pharmaceutical Technology

If approved, Welireg would be the only available therapy in the US for eligible patients with advanced PPGL.

59
article thumbnail

GSK signs £50m deal with Oxford University on cancer vaccines

The Guardian - Pharmaceutical Industry

Collaboration over at least three years aims to help understand how pre-cancerous cells develop Business live latest updates GSK has said it will spend 50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers. The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Eisai and Biogen’s LEQEMBI sBLA set for Alzheimer’s maintenance dosing

Pharmaceutical Technology

The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of Alzheimer's.

59
article thumbnail

FDA Grants Priority Review to Merck’s Welireg for Advanced, Unresectable, or Metastatic Pheochromocytoma, Paraganglioma

PharmExec

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

52
article thumbnail

BIA report: UK biotech investment surged to £3.5bn in 2024

Pharmaceutical Technology

The UK biotech sector raised 3.5bn in 2024, the highest annual total since 2021 when 4.5bn was raised.

59
article thumbnail

EMA Takes Break From X, Joins Bluesky

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Amgen opens new drug substance facility in North Carolina, US

Pharmaceutical Technology

Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North Carolina site.

59
article thumbnail

FDA Approves Supplemental Biologics License Application for Intravenous Maintenance Dosing of Leqembi in Alzheimer Disease

PharmExec

Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with Alzheimer disease administered Leqembi.

52
article thumbnail

Key Factors for Choosing a 3PL Provider

Pharmaceutical Commerce

In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, shares the elements that manufacturers should consider when selecting a 3PL.

52
article thumbnail

Exploring Biopharma's Dealmaking Terrain, Roadmap in China

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.